NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index.
The underlying index is composed of common stocks ofU. S. pharmaceutical companies.
These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
ABT | Abbott Laboratories | Healthcare | Medical Devices | 6.04% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.53% |
CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 5.22% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.02% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.96% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.94% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.83% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.44% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.06% |
PCRX | Pacira BioSciences, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | 3.95% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.95% |
BHC | Bausch Health Companies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.90% |
PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.86% |
VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.82% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.69% |
LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.61% |
TARO | Taro Pharmaceutical Industries Ltd | Healthcare | Drug Manufacturers - Specialty & Generic | 3.59% |
UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.53% |
JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.52% |
SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.47% |